Skip to main content
Category

Commentary

33rd Annual SoCal AD Research Conference

By Commentary, Community Events, Event Slider

September 9, 2022 8:00 AM – 3:15 PM PT Hybrid Event Join UCI MIND, Alzheimer’s Orange County, and Alzheimer’s Association for the 33rd Annual Southern California Alzheimer’s Disease Research Conference. This hybrid conference will cover a wide range of topics across the lifespan, such as Down syndrome, frontotemporal dementia, early-onset Alzheimer’s, the oldest-old, and even more. There are two options to join this year: In-Person: Irvine Marriott Hotel, 18000 Von Karman Ave, Irvine, CA 92612 Virtual: Registrants will be sent an email close to the conference date with instructions and links to view and participate live via Zoom Click here…

Read More

Predicting real world spatial disorientation in Alzheimer’s disease patients using virtual reality navigation tests

By Carousel Slider, Commentary, In the News

Vaisakh Puthusseryppady, a post-doctoral scholar at the University of California, Irvine in the Department of Neurobiology and Behavior writes: “As far as we are aware, this is the first study to relate patient navigation performance in VR environments to their risk for spatial disorientation in the community. An important direction for future studies would be to explore and identify VR navigation tests and measures that are effective in predicting patients’ risk for spatial disorientation in the community.” Read more in Nature here >

Read More

Early Adversity and Brain Development

By Carousel Slider, Commentary, In the News

Early life adversities can have a lifelong impact. Tallie Z. Baram, distinguished professor in the Departments of Anatomy & Neurobiology, Pediatrics, Neurology, and Physiology & Biophysics at the University of California, Irvine, determines why. Listen here > Prof. Tallie Z. Baram is the Danette Shepard Professor of Neurological Sciences, with appointments in several departments at UCI. Baram is a developmental neuroscientist and child neurologist and has focused her efforts on the influence of early-life experiences on the developing brain, and on the underlying mechanisms. She is studying this broad topic in two contexts: a) How early-life experiences, including adversity/stress, influence…

Read More

2022 Beall Scholars Program

By Commentary, Community Events, In the News

With the generous support of Don and Joan Beall, UCI MIND and its trainee organization REMIND hosted the second annual and first-ever in-person Beall Scholar Program July 18-22 on the UCI campus. The goal of the program is to inspire students who are typically underrepresented in STEM fields to pursue careers in brain research and geriatric medicine.  Sixteen rising 12th graders were chosen from a very competitive pool of applicants from Santa Ana and Anaheim Unified School Districts.  Fifty percent of the chosen scholars will be the first in their family to attend college. The program included lectures from UCI MIND faculty and trainees...

Read More

UCI research study links ALS to immune system dysfunction

By Carousel Slider, Commentary, In the News

Findings show bone marrow transplantation may be a novel treatment approach July 12, 2022 Orange, Calif. — The immune system, along with the body’s central nervous system, may play a fundamental role in amyotrophic lateral sclerosis (ALS), suggesting that bone marrow transplants may be an effective new treatment for the neurodegenerative disease, according to a research study led by Albert LaSpada, MD, PhD, a distinguished professor of pathology, neurology and biological chemistry at the UCI School of Medicine. The study, titled “Clonally expanded CD8 T-cells characterize amyotrophic lateral sclerosis-4,” recently published in the journal Nature, was a collaboration between LaSpada and microbiologists Laura…

Read More

Precision health perspectives

By Carousel Slider, Commentary, In the News

Leslie Thompson discusses how UCI’s collaborative approach can help usher in the next great advancement in healthcare July 11, 2022 In February, UCI launched the Institute for Precision Health, a campus-wide, interdisciplinary endeavor that merges UCI’s powerhouse health sciences, engineering, machine learning, artificial intelligence, clinical genomics and data science capabilities. The objective is to identify, create and deliver the most effective health and wellness strategy for each individual person and, in doing so, confront the linked challenges of health equity and the high cost of care. IPH will bring a multifaceted, integrated approach to what many call the next great…

Read More

Research reveals how brain inflammation may link Alzheimer’s risk, sleep disturbance

By Carousel Slider, Commentary, In the News

Multisite team included UCI, University of Wisconsin–Madison, Wake Forest University July 13, 2022 Irvine, Calif., July 13, 2022 – A multisite research team from the University of California, Irvine, the University of Wisconsin–Madison and Wake Forest University has discovered that brain inflammation may link Alzheimer’s disease risk with sleep disturbance, which may aid early detection and prevention efforts by identifying novel treatment targets at preclinical stages. Brain inflammation, sleep disturbance and disrupted brain waves have all been associated with Alzheimer’s disease, but the interactions among them have not been investigated until now. The study, published online today in the journal Sleep, examined…

Read More

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

By Carousel Slider, Commentary, In the News

Contributed by Mark Mapstone, PhD UCI MIND faculty Mark Mapstone, PhD and Ira Lott, MD collaborated on research that was recently published in JAMA Neurology. Learn more about their findings: Studying Alzheimer’s disease in people with Down syndrome is a very important avenue for research because nearly all people with Down syndrome will develop the brain changes of Alzheimer’s disease. These changes include the abnormal accumulation of two proteins; amyloid and tau. In this study, we wanted to know if we could measure these changes in blood and if these changes accurately reflect the changes happening in the brain.  We…

Read More

Doctors and researchers encourage people to be mindful of their brain health

By Carousel Slider, Commentary, In the News

DOTHAN, Ala. (WTVY) – Alzheimer’s and Dementia affect millions of people worldwide. Changes in the brains of people with the disease can start decades before the person actually experiences symptoms, that’s according to the AHEAD Study. With June being Alzheimer’s and Brain Awareness month, doctors and researchers of the AHEAD study are urging people to be conscious about their health and their loved ones. Doctor Josh Grill, a University of California Irvine professor, shares tips to improve and become mindful of your brain health. He said taking part in physical exercise, eating a healthy diet, getting a good night’s sleep…

Read More

How exercise may help prevent Alzheimer’s

By Carousel Slider, Commentary, In the News

Exercise could be a powerful defense against Alzheimer’s disease. Three dementia researchers explain how it works. NOVA – When it comes to dementia prevention, sleep and exercise may work together, says neuroscientist Miranda Chappel-Farley, a Ph.D. candidate at University of California, Irvine. … Together, they create a powerful bulwark against dementia and represent a lifestyle factor ignored at your peril, says Chappel-Farley, who cautions against “targeting exercise but not paying attention to sleep.” Read more here >

Read More

New treatments for psychosis in Alzheimer’s disease – pimavanserin and the FDA, redux

By Carousel Slider, Commentary, In the News

Contributed by David Sultzer, MD and Joshua Grill, PhD An FDA Advisory Committee met on June 17 to provide input to the Agency regarding the effectiveness of pimavanserin for the treatment of psychosis in Alzheimer’s disease.  The Committee voted 9 to 3, with the majority finding insufficient evidence of effectiveness in this population. This input comes on the heels of an FDA review last year that declined to approve pimavanserin for psychosis in a broad group of dementia syndromes, including Alzheimer’s disease, vascular dementia, Lewy body and Parkinson’s disease dementia, and frontotemporal dementias.  At that time, the Agency felt that…

Read More

UCI researchers aim to diversify clinical research participation with $3.7 million NIH grant

By Carousel Slider, Commentary, In the News

The multidisciplinary team will focus on participant recruitment and retainment for Alzheimer’s disease and related disorders research What is the best way to recruit participants to join a clinical studies registry, and can such registries help better diversify clinical research samples? These are two critical questions that UCI researchers are tackling with a new National Institutes of Health grant, “Recruiting and Retaining Participants from Disadvantaged Neighborhoods in Registries.” The work will be led by Joshua Grill, professor of psychiatry & human behavior in the School of Medicine and of neurobiology & behavior in the School of Biological Sciences, and by Daniel Gillen,…

Read More

UCI wins 5-year, $14M NIH grant to study brain circuits susceptible to aging, Alzheimer’s disease

By Carousel Slider, Commentary, In the News

Findings will advance development of better early diagnostic tools, new treatment strategies The University of California, Irvine has been awarded a five-year, $14 million grant from the National Institutes of Health to study brain circuits that are susceptible to aging and Alzheimer’s disease. The research findings will advance the development of early diagnostic tools and the discovery of new treatment strategies. Xiangmin Xu, Ph.D., UCI Chancellor’s Fellow of anatomy and neurobiology and principal investigator, will lead an interdisciplinary, multi-institutional team whose goal is to construct comprehensive, high-resolution maps of specific neuron types and their connections in critical brain circuits whose…

Read More

UCI MIND and UPENN Colleagues offer new guidance

By Carousel Slider, Commentary, In the News

In a blunt rejection of current norms, two leaders of biomarker disclosure research argue research participants should have the opportunity to know whether they have biomarkers of Alzheimer’s disease . Biomarkers, or biological indicators of a disease, are essential to the study and diagnosis of Alzheimer’s and other diseases that cause dementia. Clinicians use imaging such as MRI and PET scans to measure biomarkers and make accurate diagnoses. Blood tests are fast becoming available too. The tests also allow researchers to develop targeted drug therapies. But in both clinical care and research, biomarker results are infrequently disclosed. Insurers typically do…

Read More

MIND Matters | Quarterly Newsletter | Spring 2022

By Commentary, Community Events, COVID-19, In the News, Participants

Message from the Director Dear Friends of UCI MIND, Welcome to the new normal. COVID case numbers have surged again, but our research continues to push forward and our researchers have enthusiastically resumed in-person activities that have been few and far between over the last two years. This includes attending and holding scientific conferences, generally through hybrid formats, allowing those comfortable and ready to reconvene in-person to present new data, exchange ideas and forge new collaborations. Some UCI MIND investigators recently traveled to Barcelona, Spain to attend the International Conference on Alzheimer’s Disease and Parkinson’s Disease and related neurological disorders…

Read More

UCI MIND postdoctoral fellow explores the link between spatial navigation and Alzheimer’s

By Commentary, In the News

Spatial navigation is one of the cognitive processes that is affected early in Alzheimer’s disease (AD). A postdoctoral fellow in Dr. Liz Chrastil’s lab and a REMIND co-chair, Dr. Vaisakh Puthusseryppady published a paper as part of his doctoral research on the use of Global Positioning Software (GPS) to track outdoor movement patterns of people with AD in the community. He found that when alone, participants with AD tended to make fewer outings into the community, and once outside, tended to be more restricted in their movement when compared to their unimpaired counterparts.  At UCI, Dr. Puthusseryppady is advancing this work by…

Read More

Letter from the NIA acknowledges Alzheimer’s advances made at UCI MIND

By Commentary, In the News

Dr. Richard Hodes, the Director of the National Institute on Aging, published a blog about the significant progress that has been made towards advancing Alzheimer’s disease (AD) research in the past decade.  He cites several important accomplishments and specifically acknowledges the new mouse model that was developed at UC Irvine as part of MODEL-AD.  Led by Drs. LaFerla, Tenner, Green, Mortazavi, Baglietto-Vargas, and MacGregor, the team created the first animal model that closely resembles the human form of sporadic AD. Click here to read Dr. Hodes’ blog post reflecting on the 10-year anniversary of the National Plan to Address Alzheimer’s Disease

Read More

UCI MIND statement on Laguna Woods shooting

By Commentary, In the News

We at UCI MIND are heartbroken by the events of Sunday May 15 at Simpson Hall at Geneva Presbyterian Church on El Toro Road in Laguna Woods. We know very well this area, this church, and the community it serves. We have spoken previously at this very spot in partnership with the Irvine Taiwanese Presbyterian Church, sharing information about brain health and recruiting participants to our studies. All violence is senseless. Violence against people because of their race, ethnicity, political stances or other group membership is an act of hatred and even more tragic and painful. Our thoughts and prayers…

Read More

Report on Aging in Orange County 2022

By Commentary, In the News

Contributed by Orange County Aging Services Collaborative: We are excited to announce the release of the Report on Aging in Orange County 2022! This report maps the system of senior support and data available in four key areas: disability, the digital divide, food insecurity, and social isolation.Everyone is invited to read the report and are encouraged to share with your networks. Report on Older Adults in Orange County: 2022 Report on Aging in Orange County 2022

Read More

Hope Dies Last – Alzheimer’s: A Journey of Lost Memories

By Carousel Slider, Commentary, Community Events, In the News

Don’t miss this upcoming documentary filmed by OCWorld, featuring Director Dr. Joshua Grill – Tune in this Sunday on KDOCTV at 3:30pm! Contributed by OCWorld: “Tune in THIS SUNDAY on KDOCTV at 3:30pm for the premier of our final installment of our first season. This is Hope Dies Last – Alzheimer’s: A Journey of Lost Memories. This short documentary explores the impacts of Alzheimer’s disease in Orange County, a growing epicenter for the disease. Featuring insights on the disease from experts like Dr. Joshua Grill from UCI MIND and Deborah Levy, Executive Director of the Alzheimer’s Association OC Chapter.

Read More

Cell therapy: a new frontier in Parkinson’s disease

By Carousel Slider, Commentary, In the News

After decades of research into the causes and treatment of Parkinson’s disease, UCI Health neurologist Dr. Claire Henchcliffe is hopeful that a new cell therapy can finally bring meaningful relief to patients with the progressive neurodegenerative movement disorder. A national expert on Parkinson’s disease, she is one of a small group of U.S. researchers conducting a first-in-human clinical trial of transplanted stem cells engineered to replace dopamine-producing neurons that are destroyed by the debilitating and incurable condition. As the brain loses its ability to produce the potent neurotransmitting chemical, that leads to the tremors, stiffness, slowness and lack of coordination seen in Parkinson’s patients. The…

Read More

Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults

By Carousel Slider, Commentary, In the News

Blood pressure variability is an emerging risk factor for cognitive decline and dementia, but mechanisms remain unclear. The current study examined whether visit-to-visit blood pressure variability is related to CSF Alzheimer’s disease biomarker levels over time, and whether associations differed by APOE ϵ4 carrier status.

Read More

Join our team! Applications are now live for the Director of Scientific Communications

By Commentary

Join our team! Applications are now live for the Director of Scientific Communications. The University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) has an opportunity for a Project Scientist. The mission of UCI MIND is to engage in cutting edge, interdisciplinary research designed to discover the basic mechanisms of neurodegeneration and brain aging, characterize the transition from normal aging to Alzheimer’s disease, and develop new treatments to slow or eliminate cognitive impairment resulting from any etiology. Critical to this mission are dissemination of research findings to the community for the purpose of increasing public confidence…

Read More

UCI Generates Preliminary Evidence of a Gene Mutation That May Reduce Risk of Alzheimer’s Disease

By Carousel Slider, Commentary, In the News

Image Courtesy: AARP Through new developments in Alzheimer’s research, UCI scientists have uncovered evidence of P522R, a particular gene mutation that may aid in minimizing the risk of developing Alzheimer’s disease. Alzheimer’s disease is a progressive disorder that slowly deteriorates memory and thinking skills in the brain, eventually leading to a loss in the ability to complete simple tasks such as  facilitating a conversation or responding to a stimulus in the environment. With the discovery of the disease in 1906 by Dr. Alois Alzheimer, its causes today are focused on two suspects: plaques and tangles in proteins. Beta-amyloid, fragments of…

Read More

CMS Released Final Decision on Aduhelm

By Commentary, In the News

Contributed by Joshua Grill, PhD: The Centers for Medicaid and Medicare Services (CMS) recently released their final decision related to coverage for the monoclonal antibody against beta amyloid, aducanumab (Aduhelm®). The decision was expected by many and includes only a few changes from the preliminary decision announced January 11. The decision remains that CMS will pay for aducanumab under a coverage with evidence determination (CED). This means that the drug will only be covered when a person with Mild Cognitive Impairment or mild dementia is enrolled in a randomized controlled trial. Such trials will need to be approved by CMS…

Read More

For people with Down syndrome, a longer life, but under a cloud

By Carousel Slider, Commentary, In the News

The Washington Post – April 7, 2022 The FDA approval of Aduhelm ignited a raging debate, with many doctors saying they would not prescribe the drug and several insurers declining to pay for it. Yet even with the uncertainty surrounding the drug, said Elizabeth Head, [professor of pathology], at the University of California, Irvine, it is understandable why some families, especially those in which a loved one with Down syndrome faces an all but certain fate, “might believe doing something is better than doing nothing.”

Read More

Study links early life adversity, microglia dysfunction, to aberrant adult stress responses, mental illness

By Carousel Slider, Commentary, In the News

“Much of neuroscience and study of brain diseases has focused on the brain’s neurons. This study highlights that in addition to neurons, other brain cells, and especially immune cells, play crucial roles in brain health and disease,” said Tallie Z. Baram, distinguished professor in the Departments of Anatomy & Neurobiology, Pediatrics, Neurology, and Physiology & Biophysics at the UCI School of Medicine. “Neuroimmune interactions are a novel, important avenue to understanding and treating several brain disorders and mental illness and have been linked by other UCI researchers to Alzheimer’s disease.”

Read More

‘First person’ interview with Gianna Fote in the Journal of Cell Science

By Carousel Slider, Commentary, In the News

First author Gianna Fote was recently interviewed by the Journal of Cell Science for a newly-published paper. She provided commentary on her team’s new findings for UCI MIND: “In our recently published work we studied intracellular trafficking of Apolipoprotein E (APOE), a lipid-carrying protein. The APOE4 isoform of this protein is the biggest genetic risk factor for late-onset Alzheimer’s disease. We found that that APOE can be degraded by a process called autophagy, a process in which cellular waste is transported to an acidic organelle called the lysosome. The APOE4 isoform accumulates in the lysosome and causes increased induction of…

Read More

‘Anyone can get Alzheimer’s. Anyone can be a caregiver.’

By Commentary, In the News

Study reaching caregivers in underserved communities for education, coaching Associate Professor Jung-Ah Lee (right) and her caregiver study team. Caregiving is often called the invisible profession. It isn’t to Jung-Ah Lee. The associate professor at the Sue & Bill Gross School of Nursing has witnessed the burden caregivers carry, especially those caring for a loved one who has dementia. She has dedicated her career to alleviating it. With the help of a research team including community education specialists, also known as community health workers, Lee ensures that important culturally appropriate information about caregiving for someone with dementia reaches those who…

Read More

MIND Matters | Quarterly Newsletter | Winter 2022

By Commentary, Community Events, COVID-19, In the News, Participants

Message from the Director Dear Friends of UCI MIND, The COVID-19 surge caused by the Omicron variant has produced unwanted challenges for our research. Yet, our investigators remain unrelenting and highly successful in their work. Dr. Ira Lott received the international Trisomy 21 Research Society Montserrat Trueta Award (page 1). Dr. Claudia Kawas received the UCI Senate Better World Award (page 5). We honored Bob and Virginia Naeve with our UCI MIND Award, though we were unable to hold our A December to Remember Gala, to deliver it with the pomp and circumstance they deserve (page 7). Cherry Justice has…

Read More

New Preventive Vaccine for Alzheimer’s Disease Gets Grant

By Carousel Slider, Commentary, In the News

eturbonews: The Institute for Molecular Medicine (IMM), a non-profit organization dedicated to basic and translational molecular research to develop safe, effective vaccines against #Alzheimers disease and other #neurodegenerative disorders, today announced that it was awarded a $12 million grant from the National Institute on Aging (NIA) division of the U.S. National Institutes of Health (NIH)​ to support clinical trials of its beta-#amyloid (Aβ) vaccines based on DNA (AV-1959D) and recombinant protein (AV-1959R) for the prevention of Alzheimer’s disease (AD). In collaboration with the @ucirvine (Principal Investigator, David Sultzer, M.D.) and @uscedu (Principal Investigator, Lon Schneider, M.D.), IMM (Principal Investigator and…

Read More

Frequent and Feared. But Can Dementia Be Avoided?

By Carousel Slider, Commentary, In the News

Managed Healthcare Executive – March 17, 2022 According to the CDC, about 5 million Americans have Alzheimer’s disease …. “These numbers are projected to increase because elderly individuals are the fastest-growing segment in the United States,” says Claudia H. Kawas, M.D., a professor in the Department of Neurology at the University of California, Irvine, School of Medicine. … The things known about dementia risk that are potentially modifiable are all related to general health and maintenance of health, says Kawas, noting the association between control of high blood pressure and cholesterol levels and a lower risk of dementia.

Read More

Dr. Josh Grill Giving A Talk in English with Mandarin Chinese Translation 3/24/22

By Commentary, Community Events, In the News

UCI MIND Director Dr. Josh Grill is giving a talk on Zoom about Dementia Care, hosted by Happy 50 Plus, on March 24, 2022 from 4-5:30 PM. He will be speaking on “Effective Diagnosis and Treatment for Alzheimer’s, and What’s New on the Horizon.” This event will be in English with Mandarin Chinese translation. The talk is free to join, but pre-registration is required. Zoom Registration link: bit.ly/DementiaCare0324 Please see the flyer below for information regarding this upcoming event.

Read More

Inside the brain: The role of neuropathology in Alzheimer’s disease research

By Carousel Slider, Commentary, In the News

90+ Study: Learning from the oldest-old Researchers can learn a lot about how Alzheimer’s develops by studying people at increased risk. People older than age 90, or the oldest-old, are the fastest growing segment of the population in the United States and most of the world and have the highest rates of dementia. Remarkably, the oldest-old also have the highest rate of cognitive resilience and somehow avoid developing dementia despite having brain pathologies. This populations’ high rates of dementia, yet also resilience, make it an optimal group to study to understand the underlying causes of dementia. The 90+ Study, launched in…

Read More

International Women’s Day 2022

By Commentary, Community Events, In the News

This International Women’s Day, UCI MIND remains committed to understanding why almost two-thirds of Americans with Alzheimer’s are women. Research conducted in partnership with Maria Shriver’s Women’s Alzheimer’s Movement, whose organization has awarded $500,000 to UCI MIND since its launch in 2017, seeks to answer that question. Show your support by advocating, donating, and participating in research today!

Read More

Should people with Down syndrome demand coverage of Aduhelm for them?

By Commentary, In the News

Contributed by Elizabeth Head, Josh Grill, and Ira Lott People with Down syndrome are at high risk for developing Alzheimer disease beginning after the age of 40 years.  This is due, in part, to the extra copy of chromosome 21, which contains the amyloid precursor protein gene and leads to higher production of beta-amyloid with age.  Indeed, there is evidence that the overproduction of amyloid in Down syndrome is a strong driver of Alzheimer disease, which is why treatments targeting beta-amyloid could be impactful for this group of adults.  In our current exciting times, which includes the first ever approval…

Read More

Determining if Dementia Is Uniquely Human

By Carousel Slider, Commentary, In the News

Discover Magazine: Aging dogs can develop canine cognitive dysfunction (CCD), sometimes known as “doggie dementia.” The brains of dogs with CCD show only amyloid beta plaques, not tau tangles, but their symptoms are similar to the symptoms of dementia in humans, explains Elizabeth Head, [professor of medicine and] director of the graduate program in experimental pathology at the University of California, Irvine. “They’ll forget how to signal that they need to go out,” Head says. “In the more severe stages of the disease, they can become incontinent and may not recognize people.” She points out that because dogs live closely with…

Read More

Celebrating Black Americans’ contributions to Alzheimer’s research

By Commentary, In the News, Participants

Contributed by Christian Salazar, PhD Black Americans are more likely than White Americans to be afflicted with Alzheimer’s disease. This may be of no surprise considering that some of the same risk factors of heart disease that disproportionately affect African Americans in midlife- obesity, type-2 diabetes, hypercholesterolemia, hypertension- can also impact brain health later in life. Black Americans can therefore benefit from participating in clinical trials like the AHEAD 3/45 study, which aims to test whether an investigational treatment can slow or stop the earliest brain changes due to Alzheimer’s disease in people with a higher risk of developing the…

Read More

Behind a Good Mutation: UCI MIND researchers use stem cells to study a ‘genetic mutation’ that protects against Alzheimer’s Disease

By Carousel Slider, Commentary, In the News

Contributed by Hayk Davtyan, Ph.D. and Christel Claes, Ph.D. While the word “mutation” may conjure up alarming notions, a mutation in brain immune cells serves a positive role in protecting people against Alzheimer’s disease. Now UCI MIND biologists have discovered the mechanisms behind this crucial process. Their paper appears in the journal Alzheimer’s and Dementia. The investigation centered on a variant of the PLCG2 gene, which makes the instructions for producing an enzyme important to brain immune cells called microglia. “Recently the mutation, which is known as P522R, was shown to lower the risk of developing late-onset Alzheimer’s,” said Hayk…

Read More

UCI receives renewal of designation as Huntington’s Disease Society of America Center of Excellence

By Carousel Slider, Commentary, In the News

Renewal recognizes UCI’s dedication to patient care and active engagement in research to develop new therapeutic approaches February 15, 2022 “Renewal of certification as a Huntington’s Disease Society of America Center of Excellence is very exciting, as this will help us expand our patient care and research. HD was one of the first diseases for which a genetic cause was determined and serves as a paradigm for research into other such diseases,” says Leslie Thompson, Ph.D., Donald Bren and Chancellor’s professor in the departments of psychiatry and human behavior and biological chemistry at the UCI School of Medicine. UCI has…

Read More

University Of California, Irvine Launches Institute For Precision Health

By Carousel Slider, Commentary, In the News

UCI MIND #InTheNews: Forbes: “According to UCI, the new center will involve collaborations across seven areas: SMART (statistics, machine learning-artificial intelligence) designs software to integrate and analyze health records, molecular data, and observation. This unit will be led by Daniel Gillen, professor and chair of statistics, and Zhaoxia Yu, associate professor of statistics… Precision omics generates, analyzes, and administers genomic, proteomic, and chemical data. It’s led by Suzanne Sandmeyer, professor of biological chemistry, and Leslie Thompson, the Donald Bren and Chancellor’s Professor of psychiatry & human behavior at UCI… The institute will take special aim at diseases that heretofore have lacked effective treatments. “For many…

Read More

More healthy behaviors = lower risk of Alzheimer’s, research shows

By Carousel Slider, Commentary, In the News

UCI MIND #InTheNews   @Seniors Matter – Feb. 9, 2022 “People who engaged in more healthy behaviors had a lower risk than people with fewer because all of these things matter, and when it comes to brain-healthy behaviors, more is more!” said Joshua Grill, PhD, a professor of psychiatry and human behavior at the University of California, Irvine. “So, we should all try to adopt as many brain-healthy behaviors as we can.”

Read More